Thermo Fisher Scientific Inc., a maker of scientific instrument and laboratory supplies, is buying Qiagen in a deal valued at about $10.1 billion. Qiagen NV is a provider of molecular diagnostics and sample preparation technologies. The Netherlands-based company has approximately 5,100 workers at 35 locations in more than 25 countries. …read more
Source:: Yahoo Finance
